Expand VVOS Menu
VVOS MENU

VVOS Stock Posts


VVOS #VivosTherapeutics stock declines -20.6% in premarket,

Premarket Decliner

VVOS Vivos Therapeutics4.13+1.33+47.5%

Premarket:3.28-0.85 (-20.6%)

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Globe NewswireThu, 19-Sep 7:00 AM
Upcoming Earnings

VVOS Vivos Therapeutics2.08+0.07 (+3.5%)

Vivos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±12.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±12.7%. View Expected Move (Conf Call: May 14 5:00 PM)
Upcoming Earnings

VVOS Vivos Therapeutics4.70+0.05 (+1.1%)

Vivos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±38.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.4%. View Expected Move (Conf Call: Mar 28 5:00 PM)
Unusual Option Volume

VVOS Vivos Therapeutics17.59+13.20 (+300.7%)

Vivos Therapeutics trades 2,219 contracts. News: Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
View Details...
Upcoming Earnings

VVOS Vivos Therapeutics3.50+0.10 (+2.9%)

Vivos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±13.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±11.3%. View Expected Move (Conf Call: Nov 14 5:00 PM)
Upcoming Earnings

VVOS Vivos Therapeutics0.34+0.01 (+4.3%)

Vivos Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±10.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.9%. View Expected Move (Conf Call: Aug 16 6:00 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes